Xencor Licenses Antibody For Food Allergy Treatment
socalTECH
FEBRUARY 5, 2020
Monrovia-based Xencor says it has licensed the rights to its XmAB7195 monoclonal antibody, to Aimmune Therapeutics , a company that it working on treatments of food allergies. Xencor said it sold the rights to its antibody for $5 million in cash and $5 million in equity.
Let's personalize your content